Cargando…

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention

BACKGROUND: Elevated fibrinogen is associated with short‐term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown. METHODS AND RESULTS: Baseline demographics and 2‐year MACE were recorded among subjects undergoing nonemergen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ang, Lawrence, Behnamfar, Omid, Palakodeti, Samhita, Lin, Felice, Pourdjabbar, Ali, Patel, Mitul P., Reeves, Ryan R., Mahmud, Ehtisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721757/ https://www.ncbi.nlm.nih.gov/pubmed/29151032 http://dx.doi.org/10.1161/JAHA.117.006580

Ejemplares similares

The Development of Robotic Technology in Cardiac and Vascular Interventions
por: Pourdjabbar, Ali, et al.
Publicado: (2017)

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
por: Naghi, Jesse, et al.
Publicado: (2016)

Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension
por: Mahmud, Ehtisham, et al.
Publicado: (2022)

Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Mahmud, Ehtisham, et al.
Publicado: (2021)

Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
por: Walters, Daniel, et al.
Publicado: (2021)

Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study
por: Zhang, Lisha, et al.
Publicado: (2019)

Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis
por: Bhatia, Harpreet S., et al.
Publicado: (2022)

Fibrinogen–albumin ratio predicting major adverse cardiovascular outcomes post‐percutaneous coronary intervention: A systematic review and exploratory meta‐analysis
por: Desai, Rupak, et al.
Publicado: (2023)

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention
por: Gu, Lingyun, et al.
Publicado: (2021)

Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention
por: Zhao, Zi-wen, et al.
Publicado: (2019)

The Sustained Increase of Plasma Fibrinogen During Ischemic Stroke Predicts Worse Outcome Independently of Baseline Fibrinogen Level
por: Swarowska, Marta, et al.
Publicado: (2014)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease
por: Zhao, Lin, et al.
Publicado: (2023)

Polymorphisms -455G/A and -148C/T and Fibrinogen Plasmatic Level as Risk Markers of Coronary Disease and Major Adverse Cardiovascular Events
por: Canseco-Avila, Luis Miguel, et al.
Publicado: (2019)

Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?
por: Yang, Jenny Z., et al.
Publicado: (2023)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

The Impact of Admission Serum Creatinine on Major Adverse Clinical Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Vinod, Poornima, et al.
Publicado: (2018)

Association between serum hemoglobin and major cardiovascular adverse event in Chinese patients with ST‐segment elevation myocardial infarction after percutaneous coronary intervention
por: Yang, Yulu, et al.
Publicado: (2021)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis
por: Ehling, Rainer, et al.
Publicado: (2011)

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Association between baseline platelet count and severe adverse outcomes following percutaneous coronary intervention
por: Cheng, Wan–Jun, et al.
Publicado: (2018)

The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention
por: Safarian, Hadi, et al.
Publicado: (2014)

Predictors for the Development of Major Adverse Limb Events after Percutaneous Revascularization—Gender-Related Characteristics
por: Comsa, Horatiu, et al.
Publicado: (2023)

Increased cerebrospinal fluid fibrinogen in major depressive disorder
por: Hattori, Kotaro, et al.
Publicado: (2015)

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
por: Zhao, Enfa, et al.
Publicado: (2020)

Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2023)

Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Fibrinogen and albumin synthesis rates in major upper abdominal surgery
por: Dumitrescu, Gabriel, et al.
Publicado: (2022)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction
por: Shon, Ho Sun, et al.
Publicado: (2017)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Elevated plasma Galectin-3 is associated with major adverse kidney events and death after ICU admission
por: Boutin, L., et al.
Publicado: (2022)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Wang, Xianpei, et al.
Publicado: (2018)

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Qin, Zuoan, et al.
Publicado: (2021)

Predicting One-Year Deaths and Major Adverse Vascular Events with the Controlling Nutritional Status Score in Elderly Patients with Non–ST-Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Kalyoncuoğlu, Muhsin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qefrdoajbuvopnefmli6dktp6n